Merck 1Q net quadruples as cancer drug, vaccine sales soar
Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past Wall Street expectations.
Apr 30, 2019
0
675